Literature DB >> 14513560

Mobility-shift analysis with microfluidics chips.

Jarrod Clark1, Taras Shevchuk, Piotr M Swiderski, Rajesh Dabur, Laura E Crocitto, Yaroslav I Buryanov, Steven S Smith.   

Abstract

Electrophoretic mobility shift analysis (EMSA) is a well-characterized and widely used technique for the analysis of proten-DNA interaction and the analysis of transcription factor combinatorics. Currently implemented EMSA generally involves the time-consuming use of radiolabeled DNA and polyacrylamide gel electrophoresis. We are studying the bionanoscience of self-assembling supramolecular protein-nucleic nanostructures. We have undertaken these studies because they promise to enhance our understanding of assemblies formed during prebiotic evolution, provide tools for analysis of biological processes like DNA recombination, and may lead to the development of nanoscale biosensors designed for site-specific molecular targeting. During the course of that work, we noted that EMSA of these complex structures could be effectively implemented with microfluidics chips designed for the separation of DNA fragments. In this report we compare the two techniques and demonstrate that the microfluidics system is also capable of resolving complex mixtures produced by decorating DNA recombination intermediates with mixtures of DNA binding proteins. Moreover, the microfluidics chip system improves EMSA by permitting analysis with smaller samples, avoiding the use of radiolabeling, and reducing the time involved to a matter of minutes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513560     DOI: 10.2144/03353rr01

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  5 in total

1.  Biomarker identification with ligand-targeted nucleoprotein assemblies.

Authors:  Elizabeth M Singer; Laura E Crocitto; Yuri Choi; Sofia Loera; Lawrence M Weiss; S Ashraf Imam; Timothy G Wilson; Steven S Smith
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

2.  Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR.

Authors:  Kristofer Munson; Jarrod Clark; Katarzyna Lamparska-Kupsik; Steven S Smith
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

3.  Microfluidics in biotechnology.

Authors:  Richard Barry; Dimitri Ivanov
Journal:  J Nanobiotechnology       Date:  2004-03-31       Impact factor: 10.435

4.  2'-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2'-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites.

Authors:  Katarzyna Lamparska; Jarrod Clark; Gail Babilonia; Victoria Bedell; Wesley Yip; Steven S Smith
Journal:  Nucleic Acids Res       Date:  2012-07-31       Impact factor: 16.971

5.  Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.

Authors:  Elizabeth Singer; Jennifer Linehan; Gail Babilonia; S Ashraf Imam; David Smith; Sofia Loera; Timothy Wilson; Steven Smith
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.